These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10418926

  • 1. Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates.
    Vaughan HA, Ho DW, Karanikas VA, Ong CS, Hwang LA, Pearson JM, McKenzie IF, Pietersz GA.
    Vaccine; 1999 Jun 04; 17(20-21):2740-52. PubMed ID: 10418926
    [Abstract] [Full Text] [Related]

  • 2. The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan.
    Vaughan HA, Ho DW, Karanikas V, Sandrin MS, McKenzie IF, Pietersz GA.
    Vaccine; 2000 Aug 01; 18(28):3297-309. PubMed ID: 10869775
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice.
    Lees CJ, Apostolopoulos V, Acres B, Ramshaw I, Ramsay A, Ong CS, McKenzie IF.
    Vaccine; 2000 Sep 15; 19(2-3):158-62. PubMed ID: 10930667
    [Abstract] [Full Text] [Related]

  • 4. Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.
    Pietersz GA, Li W, Osinski C, Apostolopoulos V, McKenzie IF.
    Vaccine; 2000 Apr 03; 18(19):2059-71. PubMed ID: 10706970
    [Abstract] [Full Text] [Related]

  • 5. MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral.
    Apostolopoulos V, Osinski C, McKenzie IF.
    Nat Med; 1998 Mar 03; 4(3):315-20. PubMed ID: 9500605
    [Abstract] [Full Text] [Related]

  • 6. Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen.
    Lofthouse SA, Apostolopoulos V, Pietersz GA, Li W, McKenzie IF.
    Vaccine; 1997 Oct 03; 15(14):1586-93. PubMed ID: 9330472
    [Abstract] [Full Text] [Related]

  • 7. Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP).
    Apostolopoulos V, Popovski V, McKenzie IF.
    J Immunother; 1998 Mar 03; 21(2):109-13. PubMed ID: 9551361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan.
    Apostolopoulos V, Pietersz GA, McKenzie IF.
    Vaccine; 1996 Jun 03; 14(9):930-8. PubMed ID: 8843637
    [Abstract] [Full Text] [Related]

  • 10. The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1.
    Lees CJ, Apostolopoulos V, Acres B, Ong CS, Popovski V, McKenzie IF.
    Cancer Immunol Immunother; 2000 Feb 03; 48(11):644-52. PubMed ID: 10663612
    [Abstract] [Full Text] [Related]

  • 11. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
    Karanikas V, Hwang LA, Pearson J, Ong CS, Apostolopoulos V, Vaughan H, Xing PX, Jamieson G, Pietersz G, Tait B, Broadbent R, Thynne G, McKenzie IF.
    J Clin Invest; 1997 Dec 01; 100(11):2783-92. PubMed ID: 9389743
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CTL in mice immunized with human mucin 1 are MHC-restricted.
    Apostolopoulos V, Loveland BE, Pietersz GA, McKenzie IF.
    J Immunol; 1995 Dec 01; 155(11):5089-94. PubMed ID: 7594517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy.
    Karanikas V, Lodding J, Maino VC, McKenzie IF.
    Clin Cancer Res; 2000 Mar 01; 6(3):829-37. PubMed ID: 10741704
    [Abstract] [Full Text] [Related]

  • 17. Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses.
    Barratt-Boyes SM, Vlad A, Finn OJ.
    Clin Cancer Res; 1999 Jul 01; 5(7):1918-24. PubMed ID: 10430099
    [Abstract] [Full Text] [Related]

  • 18. Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.
    Heukamp LC, van Hall T, Ossendorp F, Burchell JM, Melief CJ, Taylor-Papadimitriou J, Offringa R.
    J Immunother; 2002 Jul 01; 25(1):46-56. PubMed ID: 11926165
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapy.
    Apostolopoulos V, Sandrin MS, McKenzie IF.
    J Mol Med (Berl); 1999 May 01; 77(5):427-36. PubMed ID: 10426192
    [Abstract] [Full Text] [Related]

  • 20. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.
    Stepensky D, Tzehoval E, Vadai E, Eisenbach L.
    Clin Exp Immunol; 2006 Jan 01; 143(1):139-49. PubMed ID: 16367945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.